Product Information
IVERMECTIN 1% CREAM is a generic product labeled by Viona Pharmaceuticals Inc., priced at $2.7461 per GM under NDC 72578012008. Its NADAC has been published 160 times since Sep 13, 2023.
FDA first approved this application on Aug 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578012008
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
IVERMECTINApproval Type
Generic (ANDA)
FDA Application
ANDA215210FDA Approved
8/2/2022
TE Code
AB
On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for IVERMECTIN 1% CREAM has been published 160 times since Sep 13, 2023, and over the history we have for it it has declined 42.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7461 per GM |
|---|---|
| All-time high | $5.2628 (Oct 11, 2023) |
| All-time low | $2.5224 (Jul 17, 2024) |
| 52-week high | $3.4257 |
| 52-week low | $2.7461 |
| Median price | $3.3550 |
| Average price | $3.3836 |
| Largest weekly change | +37.5% (Aug 21, 2024) |
| Weeks tracked | 160 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ivermectin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ivermectin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiparasitic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IVERMECTIN 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for IVERMECTIN 1% CREAM, manufactured by Viona Pharmaceuticals Inc., is $2.7461 per GM (NDC 72578012008), effective Sep 30, 2026.
How has the price of IVERMECTIN 1% CREAM changed over time?
Over the history we have for it, the NADAC for IVERMECTIN 1% CREAM has declined 42.5%. It has been tracked across 160 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for IVERMECTIN 1% CREAM?
Since Sep 13, 2023, the NADAC for IVERMECTIN 1% CREAM has ranged from a low of $2.5224 (Jul 17, 2024) to a high of $5.2628 (Oct 11, 2023), with a median of $3.3550 per GM.
Are there cheaper alternatives to IVERMECTIN 1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of IVERMECTIN 1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IVERMECTIN 1% CREAM?
IVERMECTIN 1% CREAM (NDC 72578012008) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.